For instance, c‐MYC can suppress BTG1 through miR‐17–92 to maintain sustained proliferation and a neoplastic state in lymphoma cells (Li, Choi, Casey, Dill, & Felsher, 2014). The gene discussed is BTG1; the disease is lymphoma.